Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TOFACITINIB for Prostate cancer: Side Effects & Safety Data

Prostate Health & Male Vitality — Naturally

ProstaVive: better flow, better sleep, better energy. 180-day guarantee.

Learn More

There are 5 adverse event reports in the FDA FAERS database where TOFACITINIB was used for Prostate cancer.

Most Reported Side Effects for TOFACITINIB

Side Effect Reports % Deaths Hosp.
Drug ineffective 30,382 19.5% 1,308 4,132
Pain 21,659 13.9% 1,649 4,320
Condition aggravated 16,925 10.9% 1,441 3,639
Arthralgia 15,640 10.1% 1,460 3,384
Fatigue 13,551 8.7% 1,643 3,450
Rheumatoid arthritis 12,277 7.9% 1,669 3,200
Off label use 11,736 7.5% 1,767 3,218
Headache 11,061 7.1% 1,302 2,294
Joint swelling 10,686 6.9% 1,703 2,877
Malaise 9,040 5.8% 1,306 2,561
Rash 8,889 5.7% 1,641 2,886
Pain in extremity 8,675 5.6% 905 1,915
Abdominal discomfort 7,966 5.1% 1,393 2,378
Diarrhoea 7,925 5.1% 1,316 2,246
Peripheral swelling 7,830 5.0% 1,256 2,295

Other Indications for TOFACITINIB

Rheumatoid arthritis (77,765) Product used for unknown indication (8,303) Psoriatic arthropathy (6,384) Colitis ulcerative (6,358) Arthritis (1,832) Psoriasis (1,130) Osteoarthritis (694) Alopecia areata (640) Crohn's disease (610) Alopecia (558)

Other Drugs Used for Prostate cancer

LEUPROLIDE (45,399) ENZALUTAMIDE (25,954) RELUGOLIX (18,752) ABIRATERONE (12,209) APALUTAMIDE (3,286) GOSERELIN (2,080) DEGARELIX (2,035) BICALUTAMIDE (1,832) SIPULEUCEL-T (1,720) DENOSUMAB (1,627)

Related Pages

TOFACITINIB Full Profile All Prostate cancer Drugs TOFACITINIB Demographics TOFACITINIB Timeline